Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis.

Indian J Pharmacol · 2010 · PMC2991692 · PMID 21189905

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

moderately significantP ≤ 0.01actually significant

Significant figures for Wilcoxon signed-rank test were: P < 0.10 —suggestive significance, P ≤ 0.05—moderately significant, and P ≤ 0.01—strongly significant.

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.